According to research on human pancreatic cancer, the proto-oncogene Kras can induce the expression of P16, and blocking the induction of P16 by Kras can lead to tumor transformation and cancer cell metastasis (Chang et al., 2014). Here, CDKN2A is linked to pancreatic neoplasm.